BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Alfa Chemistry Offers Metal Nanomaterial Products

  On August 25, 2019, Alfa Chemistry announced that they can offer various metal nanomaterial products to meet the different needs of their customers.

  August 27, 2019

   · 

  6 min read
• 

  Policy

  The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing

  The Alliance for Regenerative Medicine released a Therapeutic Developers’ Statement of Principles, setting forth a bioethical framework for the use of gene editing in therapeutic applications.

  August 27, 2019

   · 

  5 min read
• 

  Policy

  Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

  Pharmaceutical manufacturing license and GMP compliance of the Rentschler Fill Solutions plant reconfirmed by the Austrian Agency for Health and Food Safety (AGES)

  August 27, 2019

   · 

  2 min read
• 

  Presage and BMS Collaborate on Phase 0 Oncology Trials

  Despite the slow pace of its acquisition of Celgene, Bristol-Myers Squibb continues to build out its network of companies it collaborates with on the development of potential oncology treatments.

  August 27, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Bio NC

  Nanospectra’s Nanoparticle Light Therapy for Prostate Cancer Shows Promise

  AuroLase Therapy is a focal ablation treatment utilizing gold nanoparticles. The nanoparticles heat and destroy cancer cells.

  August 27, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy

  Santhera Pharmaceuticals announces publication by ReveraGen of positive study data with vamorolone in patients with Duchenne muscular dystrophy.

  August 27, 2019

   · 

  8 min read
• Policy

  Local Health Department Approaches to Opioid Use Prevention and Response Featured in New NACCHO Survey

  Local Health Departments in Colorado, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Missouri, Nevada, New Hampshire, Ohio, Pennsylvania, Tennessee, and Wisconsin Tell Their Stories

  August 27, 2019

   · 

  4 min read
• Drug Development

  InDex Pharmaceuticals Meets Primary Endpoint in the Phase IIb Study CONDUCT with Cobitolimod in Ulcerative Colitis

  InDex Pharmaceuticals Holding AB announced positive top line results from the dose optimisation study CONDUCT, which is evaluating cobitolimod for the treatment of moderate to severe ulcerative colitis.

  August 27, 2019

   · 

  6 min read
• Job Trends

  DaVita Inc. Schedules Capital Markets Day for September 10, 2019

  DaVita Inc. announced that it will hold its Capital Markets Day in New York City on Tuesday, September 10, 2019, from 8:30 a.m. to 11:30 a.m. Eastern Time.

  August 27, 2019

   · 

  2 min read
• Business

  Lannett Enters Into Advisory Services Agreement With Strategic Alliance Partner

  Lannett Company, Inc. announced that it has entered into a three-year advisory services agreement with its strategic alliance partner, Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Group.

  August 27, 2019

   · 

  2 min read